Chemotherapy for platinum-resistant/refractory
ovarian cancer is motivated by the hope of benefit.Wesought
to determine the relationships between: (a) trait hope, expectation
of symptom benefit from chemotherapy, and anxiety
and depression; (b) hope and perceived efficacy of chemotherapy;
and (c) unfulfilled hope (where expectations for benefit
are not fulfilled) and depression.